Drugs / hydroxyethylated starch
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01221389 Comparator | Mar → Dec 2012 | abdominal aortic aneurysm, blood coagulation disease | Ottawa Hospital Research Institute | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hydroxyethylated starch | “2 units of hydroxyethylated starch control solution” NCT01221389 ↗ |